SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Michelangelo Buonarroti

PatientMichelangelo Buonarroti
Date of birth1941-03-06
IdentifiersMRN HR-RE002-SYN; SSN (made up) 000-02-7781
Document date2026-10-19
AuthorSerena Castellano, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Hand osteoarthritis and gout review at about seven months. [S]

History of Present Illness

Mr. Buonarroti returns about seven months after his first visit and five weeks after his wellness visit. His hand pain stays about 3 of 10. He carves three to four hours most mornings with the splint and padded tools and writes his own letters again, if slowly. He takes acetaminophen 1 g on most days and the gel once or twice a day. He has had no gout flare, no urinary symptoms, and no falls. His DXA is booked for next week. [S]

ElementDetail
PainAbout 3 of 10
FunctionCarving three to four hours most mornings; writes his own letters
AnalgesicsAcetaminophen about 1 g a day; gel once or twice a day; no oral NSAIDs
Gout and stonesNo flare or stone
FallsNone

Review of Systems

SystemResultFinding
MusculoskeletalPositiveMild left thumb-base ache after long sessions; no swollen joints or foot pain
GenitourinaryNegativeNo flank pain, blood in the urine, or straining
GastrointestinalNegativeNo indigestion or dark stools

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ibuprofen 200 mg oral tablet (over the counter), two tablets by mouth three times dailyTwo tablets by mouth three times dailyOral route2025-12-01 to 2026-03-16stoppedS
Allopurinol 100 mg oral tablet, two tablets (200 mg) by mouth dailyTwo tablets by mouth dailyOral route2018-06-04activeS
Diclofenac sodium 1% topical gel, 2 g to the painful hand joints four times daily, no more than 8 g a day to either handApply 2 g to the affected hand joints four times dailyTopical route2026-03-16activeS
Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times daily as needed for hand pain, no more than 3 g a dayTwo tablets up to three times daily as needed; maximum 6 tablets a dayOral route2026-03-16activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-19Body height168cmS
2026-10-19Body weight61.6kgS
2026-10-19Body mass index (BMI) [Ratio]21.8kg/m2S
2026-10-19Systolic blood pressure130mm[Hg]S
2026-10-19Diastolic blood pressure76mm[Hg]S
2026-10-19Heart rate70/minS
2026-10-19Respiratory rate16/minS
2026-10-19Body temperature36.6CelS
2026-10-19Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-19Urate [Mass/volume] in Serum or Plasma5.2mg/dL3.5-7.2 mg/dLNormalS
2026-10-19Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-10-19Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
2026-10-19Carbon dioxide, total [Moles/volume] in Serum or Plasma25mmol/L22-29 mmol/LNormalS
2026-10-19Urea nitrogen [Mass/volume] in Serum or Plasma19mg/dL8-23 mg/dLNormalS
2026-10-19Creatinine [Mass/volume] in Serum or Plasma1mg/dL0.74-1.35 mg/dLNormalS
2026-10-19Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M74mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-10-19Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-10-19Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma17U/L7-55 U/LNormalS
2026-10-19Pain severity - 0-10 verbal numeric rating [Score] - Reported3{score}S
2026-10-19PROMIS upper extremity version 2.0 T-score43{T-score}S
2026-10-19Grip strength Hand - left Dynamometer18kgS
2026-10-19Grip strength Hand - right Dynamometer23kgS

Physical Exam

Vital signs recorded on 2026-10-19; see the Vital Signs section. [S]

SystemFinding
GeneralWell
Left handThumb-base squaring with slight tenderness; no synovitis; thumb abduction a little better than in the spring
Right handHeberden nodes; no synovitis
FeetNo tophi or swelling

Problems

ProblemClinical statusVerificationCodeProvenance
Primary osteoarthritis of the left hand, worst at the thumb base (first carpometacarpal joint, Eaton stage III), with thumb metacarpophalangeal and interphalangeal and index metacarpophalangeal and proximal interphalangeal involvement; non-erosiveactiveconfirmed M19.042S — Synthetic modern diagnosis confirmed by examination and radiographs. The joint pattern echoes the retrospective portrait-based interpretation (R, possible), which remains a hypothesis about the historical person; his documented difficulty writing is D.
Primary osteoarthritis of the right hand, mild, with Heberden nodes of the index and middle fingersactiveconfirmed M19.041S — Synthetic modern diagnosis; the portraits studied show only the left hand.
Chronic gout without tophi, in remission on allopurinol with serum urate at targetactiveconfirmed M1A.9XX0S — Synthetic modern diagnosis, crystal-proven years ago in the synthetic history. Gout in the historical person is a retrospective reading of period language (R, possible).
History of urinary stones, passed spontaneously years ago; stone-free on fluids and allopurinolactiveconfirmed Z87.442S — Synthetic modern entry linked to the urinary calculus documented in his own letters (D); the composition of his historical stones is not known.
Laceration of the left index finger from a slipped chisel, 2.5 cm, without tendon, nerve, or nail injury; repaired and healedresolvedconfirmed S61.211AS — Synthetic injury at an unscheduled visit; weak pinch grip from thumb-base osteoarthritis let the chisel slip. It does not echo a documented injury.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyHand pain, 0 to 10 numeric ratingEach clinical encounter; after each therapeutic trialCompleted today3 of 10
SurveyValidated function measure (PROMIS upper extremity T-score; AUSCAN and FIHOA have no LOINC code)Each clinical encounterCompleted todayT-score 43 (population mean 50; higher is better)
ExaminationGrip strength by dynamometerEach clinical encounter in this planCompleted todayLeft 18 kg, right 23 kg
ExaminationJoint examinationEach clinical encounterCompleted todayNo synovitis; slight thumb-base tenderness
LaboratoryALT on regular acetaminophenPeriodically, especially near 3 g a dayCompleted today17 U/L
LaboratorySerum urateEvery 6 months at targetCompleted today5.2 mg/dL: at target
LaboratoryCreatinine and eGFR for allopurinol dosing and analgesic safetyEvery 6 to 12 monthsCompleted todayCreatinine 1.00 mg/dL, eGFR 74; potassium 4.4 mmol/L
Medication safetyAnalgesic review: no oral NSAIDs; acetaminophen doseEach clinical encounterCompleted todayNo ibuprofen; acetaminophen about 1 g a day
ImagingHand radiographsNot for routine follow-upNot indicatedClinical improvement; no repeat imaging
SurveyMood, sleep, and coping screenPeriodicallyUp to datePHQ-2 score 0 at the September wellness visit
Self-managementExercise, joint protection, and splint useEach clinical encounterCompleted todayDaily exercises; splint for carving
Self-managementGait, balance, and fallsOngoingUp to dateNo falls; Timed Up and Go 11 seconds in September; DXA booked next week
Self-managementFluid intake for stone preventionEach clinical encounterCompleted todayAbout 2 L of water a day

Goal progress:

Guideline basis: 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); 2020 American College of Rheumatology Guideline for the Management of Gout (2020); Medical Management of Kidney Stones: AUA Guideline (2014, amended 2019); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); CMID: Clinical Monitoring Intelligence Database, rheumatoid arthritis and osteoarthritis monograph (2026); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); Osteoporosis to Prevent Fractures: Screening (2025)

Follow-up: DXA next week, with a call about the result. Hand and gout review in six months with serum urate. [S]